ADVA
8.9.2020 09:02:18 CEST | Business Wire | Press release
ADVA (FSE: ADV) today announced that the Luxembourg Commercial Internet Exchange (LU-CIX) is increasing the security and availability of its services with the ADVA ALM fiber monitoring solution. The technology provides real-time network visibility, enabling LU-CIX to quickly locate and resolve all fiber issues. Deployed in the internet exchange company’s backbone infrastructure, the ADVA ALM delivers comprehensive in-service assurance. It’s now empowering LU-CIX to accurately pinpoint areas of degradation, instantly initiate countermeasures and redirect traffic away from degraded optical paths. The compact and low-power solution helps avoid outages and enables LU-CIX to track its SLAs. ADVA’s partner Telindus, a brand of Proximus Luxembourg, also played a key role in the deployment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200908005221/en/
“We needed a solution that delivers precise, automated, up-to-the-minute root-cause analysis combined with permanent measurement. That’s why we chose the ADVA ALM. It enables our team to tackle issues more quickly and efficiently, while also addressing an area of security exposure,” said Michel Lanners, CIO, LU-CIX. “One of the key advantages of the ADVA ALM is that it offers significant improvement without a major addition to our existing network. It delivers total insight and full control without significant investment. What’s more, the technology enables us to improve the integrity of our network and detect eavesdropping attacks. With the ADVA ALM, we can remotely measure attenuation and stay one step ahead of attacks using a splitter or bending coupler.”
The ADVA ALM is now delivering precise, real-time insight into the integrity and performance of LU-CIX’s optical transport infrastructure. With its ease of use and intuitive GUI, the in-service monitoring equipment provides complete network assurance, enabling the root cause of link outages to be immediately pinpointed. Issues can now be identified in seconds and the right measures engaged, saving the company both time and money. The ADVA ALM also makes it straightforward to separate faults with active devices from problems in the fiber plant. Another key advantage is its transparent, service-agnostic monitoring, which is completely independent of transported data. That means the ADVA ALM delivers complete assurance with no application interference.
“Our ALM now ensures that LU-CIX has an intricate understanding of its fiber network. For maintenance teams, that means no more false alarms, no unnecessary site visits and no wasted hours finding faults. Now problems can be diagnosed and dealt with long before they affect services. Not only will this help to reduce operational expenses and maximize resource efficiency, but it’s also a key tool for maintaining valuable SLAs,” commented Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “LU-CIX is crucial to Luxembourg’s internet sector and one of Europe’s key internet hubs. By harnessing our unique plug-and-play device to further enhance the stability and efficiency of its infrastructure, it can continue to provide a secure and trusted environment in the heart of Europe.”
“This deployment is already bringing major benefits to LU-CIX and its customers. It’s enabling the internet exchange to avoid performance issues by rapidly responding to defects and degradation in its fiber network. Now LU-CIX can proactively reroute traffic and operating teams can take targeted action to fix faults,” said William Malingrey, pre-sales consultant, network solutions, Telindus. “We’re committed to providing the most innovative technologies available to support our customers’ business strategies and digital transformation. The ADVA ALM is a uniquely affordable and space-efficient solution that makes a real difference. It’s now giving LU-CIX total visibility and control of its fiber assets and supporting simpler, more cost-efficient and more sustainable practices.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About LU-CIX
LU-CIX, the LUxembourg Commercial Internet eXchange was founded in 2009 based on a not-for-profit membership association with an open and neutral philosophy. Its aim is to develop the Internet and support the data center community in Luxembourg. As well as providing the technical infrastructure LU-CIX also makes a major contribution to the Luxembourg Internet community through its leading industry event, Luxembourg Internet Days, which takes place in November every year and attracts over a thousand industry experts and decision makers from around the globe. LU-CIX also runs the datacenters-in-europe.com website, which provides a shared communication platform for all the players in the Luxembourg data center and Internet arena and promotes Luxembourg as the best place for your European data center and ICT business in the heart of Europe. More information at www.lu-cix.lu .
Published by:
ADVA Optical Networking SE, Munich, Germany
View source version on businesswire.com: https://www.businesswire.com/news/home/20200908005221/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom